Sponsor

Prothena Biosciences Limited

Clinical research sponsor

Published trials6

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

6 shown

Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's DiseaseNCT02157714 · lead sponsor · 2014-06-01

COMPLETED

Single Ascending Dose Study of PRX002 in Healthy SubjectsNCT02095171 · lead sponsor · 2014-03-01

COMPLETED

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseNCT07174310 · collaborator · 2025-11-24

RECRUITING

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseaseNCT04777331 · collaborator · 2021-05-05

ACTIVE_NOT_RECRUITING

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's DiseaseNCT03100149 · collaborator · 2017-06-27

ACTIVE_NOT_RECRUITING

Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's DiseaseNCT03043768 · collaborator · 2016-06-01

COMPLETED

Sponsor roles

collaborator4

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.